Suwanee, GA, United States of America

Xuan Guo

This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 8 EPO patents. Top assignees: Merial Limited, Biolex Therapeutics, Inc., Boehringer Ingelheim Animal Health USA Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuan Guo. Retrieved from https://idiyas.com/inventor/xuan-guo-pa3valxo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xuan Guo: A Pioneer in Veterinary Vaccines

Introduction: Xuan Guo is an innovative inventor based in Suwanee, Georgia, known for his significant contributions to the field of veterinary medicine. With a total of four patents to his name, Guo has focused on the development of advanced vaccine technologies aimed at protecting animals from various infectious diseases.

Latest Patents: Among his latest patented inventions is a recombinant Newcastle Disease Virus (NDV) antigen and its applications. This invention introduces NDV vaccines that utilize a subunit approach based on the Hemagglutinin-Neuraminidase (HN) protein of the NDV, expressed in plants or algae, including microalgae. Guo's work also includes the development of recombinant vectors that encode and express NDV antigens, epitopes, or immunogens, designed to enhance protection for animals against NDV. His vaccine innovations incorporate a vaccination regime aligned with the DIVA (Differentiating Infected from Vaccinated Animals) strategy, which features a prime-boost scheme employing viral vector vaccines, inactivated vaccines, and subunit vaccines. Additionally, Guo has developed recombinant vaccines for Bluetongue Virus (BTV), offering compositions that may include BTV antigens and employing similar recombinant strategies to protect livestock, such as sheep, cattle, and goats.

Career Highlights: Guo has made a substantial impact in the biotech industry through his tenure at prominent companies like Merial Limited and Biolex Therapeutics, Inc. His career reflects a commitment to research and innovation in veterinary medicine, contributing valuable knowledge and solutions to the field.

Collaborations: Throughout his career, Xuan Guo has collaborated with talented professionals, including Joyce Pritchard and Michel Joseph Bublot. These partnerships have facilitated the advancement of his inventions and broadened the scope of his research initiatives.

Conclusion: Xuan Guo exemplifies the spirit of innovation in the development of veterinary vaccines. His patented inventions, particularly in NDV and BTV vaccine technologies, underline his dedication to animal health and contribute to the advancement of veterinary medicine. As the field continues to evolve, Guo's contributions will play a crucial role in enhancing disease protection for animals across the globe.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…